Analyst Price Targets — FUL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 26, 2026 1:55 pm | — | UBS | $69.00 | $63.38 | StreetInsider | HB Fuller (FUL) PT Lowered to $69 at UBS on Lower 2026 Earnings OutlookMember Login |
| June 26, 2026 6:54 am | — | Goldman Sachs | $67.00 | $61.95 | StreetInsider | JPMorgan Upgrades HB Fuller (FUL) to Overweight |
| June 26, 2026 6:54 am | — | Raymond James | $67.00 | $61.95 | StreetInsider | JPMorgan Upgrades HB Fuller (FUL) to Overweight |
| June 17, 2026 12:20 pm | — | UBS | $71.00 | $65.61 | TheFly | H.B. Fuller price target raised to $71 from $63 at UBS |
| May 27, 2026 6:38 am | — | UBS | $58.00 | $60.56 | StreetInsider | JPMorgan Upgrades HB Fuller (FUL) to Neutral |
| May 27, 2026 6:38 am | — | RBC Capital | $58.00 | $60.56 | StreetInsider | JPMorgan Upgrades HB Fuller (FUL) to Neutral |
| March 27, 2026 1:18 pm | — | UBS | $63.00 | $59.17 | TheFly | H.B. Fuller price target lowered to $63 from $66 at UBS |
| March 27, 2026 11:28 am | Kevin McCarthy | Vertical Research | $73.00 | $59.17 | TheFly | H.B. Fuller upgraded to Buy from Hold at Vertical Research |
| January 16, 2026 3:12 pm | Michael Harrison | Seaport Global | $84.00 | $60.62 | TheFly | H.B. Fuller price target raised to $84 from $80 at Seaport Research |
| January 16, 2026 12:21 pm | — | UBS | $66.00 | $63.49 | TheFly | H.B. Fuller price target raised to $66 from $60 at UBS |
Latest News for FUL
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, pay
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable on August 13, 2026 to shareholders of record at the close of business on July 30, 2026.H.B. Fuller has paid quarterly cash dividends on its common stock for 58 consecutive years.About H.B. FullerAs the largest pureplay…
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still clouds its path to stronger growth.
FUL trades near the low end of its five-year valuation range as improving earnings meet volume, inflation and leverage risks tied to its medical-market expansion.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FUL.
U.S. House Trading
No House trades found for FUL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.